Donald J. Santel

Insider Reports History

Entity
Individual
Location
4362 24 Th Street, San Francisco, CA
Signature
/s/ George A. Eldridge, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Donald J. Santel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aerovate Therapeutics, Inc. Director Stock Option (Right to Buy) 12.5K $205K $16.37 Jun 5, 2024 Direct
Surrozen, Inc./DE Former Director Common Stock 30K $11.4K $0.38 Aug 11, 2021 Direct
Oyster Point Pharma, Inc. Director Common Stock 0 $11.20 Jan 3, 2023 Direct
Oyster Point Pharma, Inc. Director Stock Option (Right to Buy) 0 Jan 3, 2023 Direct
Surrozen, Inc./DE Former Director Class B Ordinary Shares 0 Aug 11, 2021 Direct

Insider Reports Filed by Donald J. Santel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVTE Aerovate Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
AVTE Aerovate Therapeutics, Inc. Jan 2, 2024 1 $39K 4 Jan 4, 2024 Director
AVTE Aerovate Therapeutics, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
AVTE Aerovate Therapeutics, Inc. Jan 19, 2023 2 $39K 4 Jan 23, 2023 Director
AVTE Aerovate Therapeutics, Inc. Jan 19, 2023 0 $0 3 Jan 23, 2023 Director
OYST Oyster Point Pharma, Inc. Jan 3, 2023 4 $0 4 Jan 4, 2023 Director
OYST Oyster Point Pharma, Inc. Jun 6, 2022 2 $0 4 Jun 8, 2022 Director
SRZN Surrozen, Inc./DE Aug 11, 2021 2 $0 4 Aug 13, 2021 Former Director
OYST Oyster Point Pharma, Inc. Jul 30, 2021 4 $0 4 Aug 3, 2021 Director
OYST Oyster Point Pharma, Inc. Jul 30, 2021 0 $0 3 Aug 3, 2021 Director